chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received on 21 August 2009 from a health care professional. A 4-year-old male patient, who had no concurrent illnesses, no know allergies, no reported relevant medical history or use of other medications, had receive on 18 August 2009 a dose of DAPTACEL (lot number C3139AA); an injection of TUBERSOL 5TU (lot number C3149AA); a dose of PNEUMOVAX (manufacturer Merck, lot number not reported); and a third dose of "HEP B" (Trade name, manufacturer name and lot number not reported). The routes and sites for all vaccines were not reported. The following day after receiving the vaccinations, the patient's parent reported the patient had a fever of 103.8 degrees Fahrenheit at home, and the patient was subsequently evaluated at th physician's office where his fever was recorded as 103.1 degrees Fahrenheit. It was not reported whether the patient received any treatments at that time. The parent also reported that two days after receiving the DAPTACEL vaccine (site not reported), the site of injection was erythematous, mottled and warm to touch, but without any complaint of pain. It was not reported whether any treatment were received, or if any diagnostic tests or laboratory data were performed. The recovery status was not reported. Documents held by sender: None
DTAP about 09:00: Warm shoulder and slightly red that same 1 day later.  8x9 cm red, hot, tender lesion right shoulder.  Right rash gone 08/29/2003.
Information has been received from a registered nurse concerning a 54 year old male patient with history of "immunosuppression of unspecified etiology" who on 02-FEB-2010 was vaccinated intramuscularly with his first 0.5 ml dose of PNEUMOVAX 23 (Lot # 664537/1193Y). It was reported that one day after receiving the PNEUMOVAX 23, on 03-FEB-2010, the patient experienced an injection site reaction, he was seen at the office exhibiting redness, swelling and severe pain at the injection site and down the arm. No treatment was prescribed. The patient recovered within one week, on approximately 10-FEB-2010. No diagnostic tests were performed. This report is related with WAES # 1003USA00920, WAES # 1003USA00981, WAES # 1003USA00983 and WAES # 1003USA00984, same source, same adverse experienced. Additional information has been requested.
Pt developed immediate SOB and syncope. Was hospitalized from 10/28/16 to 11/1/16 for cardiac arrest following Pneumovax. She then was readmitted 11/9/16 and died.
inflammation/had inflammation on hands and feet and face; head fogginess; hives on her back and chest/ few hives and raised welts on her back; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Dec2021 (Lot number: FH8030) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy medication" (unspecified if ongoing), notes: She would take an allergy medication periodically prior to this. only take it if she needs. There were no concomitant medications. The following information was reported: URTICARIA (non-serious) with onset 02Dec2021, outcome "recovering", described as "hives on her back and chest/ few hives and raised welts on her back"; HEADACHE (non-serious) with onset 02Dec2021, outcome "recovering", described as "headache"; FEELING ABNORMAL (non-serious) with onset 03Dec2021, outcome "recovering", described as "head fogginess"; INFLAMMATION (non-serious) with onset 04Dec2021, outcome "recovering", described as "inflammation/had inflammation on hands and feet and face". Therapeutic measures were taken as a result of urticaria.  Additional information: Patient stated that she received her first dose of the vaccine last 02Dec2021 and on the same day she developed hives on her back and chest, experiences headache. She had head fogginess that started the next day on 03Dec2021 and then, she also had inflammation on her hand and a little on her face and feet started on 04Dec2021. She also stated that the hives lasted for two weeks. She took an allergy medication Allegra', to offset it when she started feeling the reaction on 03Dec2021, and the hives are just starting to feel better on 10th day, she would only take medicine if she needs to. She would take an allergy medication periodically prior to this. She just doesn't like taking medications and she would only take it if she needs to. She wanted to know if she can get her 2nd dose after experiencing this side effects. She does not think she is a candidate for second dose and wanted to ask someone guidance about getting second dose based on her symptoms.   No follow-up attempts are possible. No further information is expected.
excruciating pain in my left thigh/pain has spread past down my knee; swelling in my left thigh; constant spasms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (excruciating pain in my left thigh/pain has spread past down my knee), PERIPHERAL SWELLING (swelling in my left thigh) and MUSCLE SPASMS (constant spasms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (excruciating pain in my left thigh/pain has spread past down my knee), PERIPHERAL SWELLING (swelling in my left thigh) and MUSCLE SPASMS (constant spasms). At the time of the report, PAIN IN EXTREMITY (excruciating pain in my left thigh/pain has spread past down my knee), PERIPHERAL SWELLING (swelling in my left thigh) and MUSCLE SPASMS (constant spasms) outcome was unknown.            No concomitant medications were provided.  No treatment was reported for the events.
The patient reported aches, chills and a headache that lasted for one day after receiving the vaccination.
Pt recv vax on 10/10/97; immediately post vax pt exp tingling in hands, feet & legs
muscle twitching elevated D-dimer r/t recent surgery & COVID vaccine per ER progress note Per admission H&P "vaccine reaction likely more serotonin syndrome, possibly exacerbated by vaccine; tolerated initial COVID series well (Moderna vaccines for all 3)"
The patient was admitted to Health and Rehab from home with a history of generalized weakness, inability to walk and inability of his family to care for him.  The patient had a history of carcinoma of the prostate and was treated with antiandrogen drugs.  The patient was admitted for palliative care.  The patient tested positive for Covid 19 on 2/14/22.  The patient expired on 3/2/2022.
I am postmenopausal. I had a full menstrual period in August 2021.  I had additional very light bleeding in October 2021
hives up neck and scalp, spreading to trunk.  nov 8 went to ER, Decadron 4 I'm and after prednisone 20mg x2 days not helping, increased to 60mg.
Patient received booster before 18 years of age - no adverse reactions noted as of today 12/8/2021.
Patient fainted about 10 minutes after vaccine administered. Came to within a couple of minutes and vitals were stable upon examination by EMT's within about 15 minutes.
patient recieved 4 vaccines as part of preparation for missionary service. Flu, mmr, tdap, menactra.  within 5 minutes patient began to feel faint and light headed then mentioned difficulty breathing and was advised to sit down. patient fainted shortly after and was unconscious. pharmacist administered one dose of epinephrine and patient was lain down on floor with feet elevated. Technician called 911 and paramedics arrived shortly thereafter.  Patient was conscious and resting when paramedics arrived.  Parents were called and arrived shortly after paramedics.  patient was well and left with parents. no other interventions given.
Received J+J Covid vaccine on 4/3/21. Admitted on 4/19. Per admission note: Patient is a 36YO male with a history of HFrEF s/p heartware 12/17/14, ICM with embolic MI, CAD, chronic driveline infection, HTN, HLD, DM type II, SVT, obesity, gout who was sent to the hospital for bilateral PEs. Patient called our OP line on 04/17 complaining of fever of 102 and chills. He was instructed to go to local lab and get labs done. They drew basic labs as well as blood cultures. On Sunday, the patient reported his fever was gone and he felt better. Today, he was feeling SOB and presented to his PCP. They ordered a CTA which reportedly showed bilateral PEs. They sent him to the local ED who transferred him here. Of note, his INR has been supratherapeutic for several weeks and pharmacy has been adjusting his warfarin dosing. The patient tested COVID negative prior to transfer. The vaccine lot number information is not accessible to this reporter.
Joint pain, muscle pain, headache, fever and injection site swelling. Five days later, the injection site is red, swollen, itchy, sore and extends down my arm about 7 inches long by about 4 inches wide.  Every joint and muscle in agony for about 36 hrs.  Unable to function for 24 hrs. I have an extremely high pain tolerance and rarely have side effects with medication.  I took lots of ibuprofen for 24 hrs.  My dr. and pharmacist recommended I file this report.  I will not be getting dose 2 of this vaccine.
patient developed a hive appearance rash on 1 side of the face approx. 2 hrs. after receiving her 1st dose of gardasil.  The following day rash deeper red with small bumps and itchy.  Same rash developed on cheeks  bilaterally by day 3, and continued times 5 days total.  Benadry given times 4 doses for 48 hrs. after injection.   day 5 patients skin on cheeks peeled as if sunburned.
Arm was sore; Headache; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) and HEADACHE (Headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm was sore) and HEADACHE (Headache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information was not provided.  It was reported that soreness in arm and headache resolved within a couple of days.   This case was linked to MOD-2021-403043 (Patient Link).
Only the adjuvant was given; Only the adjuvant was given; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number 7C4B3, expiry date 14th November 2022) for prophylaxis.   On 20th August 2021, the patient received Shingrix. On 20th August 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter stated that, the patient received only the adjuvant portion of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This case was linked with cases US2021182200, US2021182199, reported by same reporter for differnt patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021182199:Same reporter US-GLAXOSMITHKLINE-US2021182200:Same reporter
This spontaneous report was received from a Licensed practical nurse refers to a multiple unspecified patients of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On an unknown date, the multiple unspecified patients were vaccinated with improperly stored PROQUAD, therapy type: RHA, Lot# M011661 (expiry date: 08-SEP-2017) (dose not reported). No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of two reports received from the same reporter. Additional information has been requested.
SkinRash, Rash, UrticariaPruritus, red/swelling to injection site; rash to chest and upper back Narrative: Day 1 - itchiness, redness and swelling to injection site; day 2-6 non-itch rash to chest and upper back
Breakthrough COVID case; fatigue, sore throat, headache initially, then progressed to sinus congestion, excessive mucous production, cough; fever x 1 day 2/9/22; progressed to chest congestion and productive cough
After I received the 2nd dose of the vaccine a dark spot appeared at the end of my nose and its really itchy. I mentioned it to my doctor  but he didn't act like it was a concern or a big deal. My nose it still itchy and bothers me, my doctor did not prescribe any medicine.
Fatigue (lasting) "Covid Arm" Dermatitis (Starting 4/12/21)
tingling on his hands and finger tips\ Tingling on the finger tips; This case was reported by a consumer via call center representative and described the occurrence of tingling of extremity in a male patient who received Rabies NVS (RabAvert) for prophylaxis.   On 20th November 2019, the patient received RabAvert 1 ml. In November 2019, less than a week after receiving RabAvert, the patient experienced tingling of extremity. On an unknown date, the outcome of the tingling of extremity was unknown.   It was unknown if the reporter considered the tingling of extremity to be related to RabAvert.  Additional case details were reported as follows: The age at vaccination was not reported. It was unknown if the patient received RabAvert vaccination for pre or post exposure prophylaxis. The patient reported tingling on his hands and finger tips after receiving Rabavert on last Wednesday. No specific data from product was clarified.
pt recvd 1st dose of Hep B vax on 29JAN92 & w/in 24 hrs of receiving vax pt devel generalized diffuse urticaria;
Headache, Myalgia, Arthralgia, Localized pain; chills, fatigue Narrative:  Other Relevant History:
blood clots were found in my right leg, 6 to be exact, no known origin of the clots. Had a stent placed on 3/9 almost lost my big toe and pinky on right foot. Now i am experiencing bp spikes that have gone up to 220/100 and drop within 15 mins. No known origin. They cannot put me on blood pressure meds because it drops so quickly without medication.
pt napped p/vax but woke up screaming & cont for 3 hrs w/o relief; crying was high pitched & very different from nl cries;
In 1999, soon after the vax, the pt developed generalized measles rash characterized by "fine red sand paper rash" with fever of 105. Subsequently the pt's symptoms resolved. No further details were available.
About 12 hours after receiving the vaccine, I developed a red, itchy, raised hive about 1 inch in diameter at the injection site.
vertigo 48 hours after administration of ENGERIX B with dizziness, unsteady gait, nystagmus, nausea, photophobia. VS WNL. Similar but milder reaction after 1st dose of Hep B.
At the injection the patient started to faint  his mother was there  and knew what was needed   patient came back around and stayed seated for 45 minutes  Mother took him to ER for observations
Increased Menstrual Bleeding  from 1 day to 3 days (After Second Vaccine); Feels Something is Wrong with Body (After Second Vaccine); Very Tired (After Second Vaccine)/Intermittent Severe Fatigue (After Second Vaccine); Intermittent Body Pain (After Second Vaccine); This spontaneous case was reported by a health care professional and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Increased Menstrual Bleeding  from 1 day to 3 days (After Second Vaccine)), MALAISE (Feels Something is Wrong with Body (After Second Vaccine)), FATIGUE (Very Tired (After Second Vaccine)/Intermittent Severe Fatigue (After Second Vaccine)) and MYALGIA (Intermittent Body Pain (After Second Vaccine)) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Increased Menstrual Bleeding  from 1 day to 3 days (After Second Vaccine)), MALAISE (Feels Something is Wrong with Body (After Second Vaccine)), FATIGUE (Very Tired (After Second Vaccine)/Intermittent Severe Fatigue (After Second Vaccine)) and MYALGIA (Intermittent Body Pain (After Second Vaccine)). At the time of the report, HEAVY MENSTRUAL BLEEDING (Increased Menstrual Bleeding  from 1 day to 3 days (After Second Vaccine)), MALAISE (Feels Something is Wrong with Body (After Second Vaccine)), FATIGUE (Very Tired (After Second Vaccine)/Intermittent Severe Fatigue (After Second Vaccine)) and MYALGIA (Intermittent Body Pain (After Second Vaccine)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was reported.
Information has been received from a medical assistant concerning a 9 year old female who was vaccinated with the first dose of Gardasil. It was reported that the patient appeared to be nervous prior to vaccination, and subsequently, 5-10 seconds after vaccination the patient fainted. The patient's mother caught her so that she did not fall and incur any additional injury. The patient sought unspecified medical attention. It took 5-10 minutes for the patient to fully recover, and then she was able to leave the office. Additional information has been requested. This is one of two reports received from the same source.
patient filled out the consent form and was verbally confirmed to have not received any covid shot.  It was later discovered via immunization portal that patient had Janssen covid shot in March after insurance rejection prompted.
Muscle pain, muscle weakness whole body, fever, chest pain, fever > 100 degrees, chills, headache, fatigue.
Chills, Fever, Headache, Nausea, muscle pain and weakness, a feeling of diarrhea but no diarrhea.  This lasted for 24 hours.
PATIENT REPORTED FEELING FAINT AND A RAPID HEARTBEAT AFTER THE VACCINE WAS GIVEN. EMS WAS CALLED AND THEY EVALUATED PATIENT AND TOOK HER TO THE ER.
Tingling in Extremities; Flushing; Desperate Itch All Over Body/developed itching; Muscle Aching After Rest; Temperature of 100 degrees F; This spontaneous case was reported by a nurse and describes the occurrence of PARAESTHESIA, FLUSHING, PRURITUS, MYALGIA, and PYREXIA in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Itching all over.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced PARAESTHESIA, FLUSHING, PRURITUS, MYALGIA, and PYREXIA. At the time of the report, PARAESTHESIA, FLUSHING, PRURITUS, MYALGIA, and PYREXIA outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 100 °F (Borderline).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment for the event included periactin three times per day.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt reports received first shingrix dose 5/20/19 in morning. That afternoon developed fever, chills, body aches, resolved after 24 hours. 16 days later same exact symptoms happened and resolved again in 24 hours.  No other vaccines given that day pt reports.
Adverse Events:  right sided arm tingling/numbness, tingling to right side of face, tingling to right side of throat about an hour after first dose of Pfizer COVID vaccine.  I felt dyspnea and "one moment" sensation of throat closing which resolved with deep breathing. I felt  weakness in right arm/hand and had difficulty writing. Right sided facial droop and dizziness.  Treatment:  called vaccine clinic and they told me to go to immediate care or ER.  Went to immediate care and they took vitals and suggested I go to ER due to it being single sided.    ER Visit:  bloodwork done by ED physician.   OUTCOME: Re-assessment: (12:40): -Patient was reassessed and patient/family was updated on the results.  -Patient's condition has improved, vital signs are stable, and no new complaints are reported.  -A repeat exam reveals no new  worrisome changes from initial exam findings.   -The patient was comfortable being discharged.  Discussed the plan and they are comfortable with this.  - I discussed with the patient any abnormal labs or imaging.  I discussed with the patient that they must followup with a physician tomorrow.  Diagnosis: Paresthesias
Injection site pain immediately after and continuing currently at 3:34 am. Extreme chills starting 1 am still in effect currently at 3:34 am. 101.4 Fever recorded from armpit at 3 am, have taken suggested dose of ibuprofen, still at same temp now half hour later. Loss of balance/lightheaded noticed at 3 am, still in affect now, a half hour later.
Pt received vaccine on Sat 9/11 .  She reports monday not feeling good at all.  Tuesday she had burning, Wednesday she had eruption of shingles on side of lower back.  Her Dr started valtrex 500mg 1bid for 14 days on Friday 9/17.  Pt reports it hurts to have her shirt on.    She asked that we report this as an adverse event from moderna vaccine.